Can estragole in fennel seed decoctions really be considered a danger for human health? A fennel safety update

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Gori, L ^a   Gallo, E ^a   Mascherini, V ^a   Mugelli, A ^a   Vannacci, A ^a   Firenzuoli, F ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA PHELLANDRENE; ANETHOLE; APIGENIN; BETA PINENE; CARCINOGEN; COUMARIN; ELEMICIN; ESSENTIAL OIL; ESTRAGOLE; FENNEL OIL; FLAVONOID; KAEMPFEROL; LIMONENE; LUTEOLIN; METHYLEUGENOL; MYRCENE; MYRICETIN; MYRISTICIN; NEVADENSIN; O DEMETHYLASE; PARA CYMENE; PINENE; PLANT EXTRACT; QUERCETIN; SAFROLE;

ANTIOXIDANT ACTIVITY; BIOTRANSFORMATION; CARCINOGEN DNA INTERACTION; CARCINOGENICITY; CYTOTOXICITY; ENZYME ACTIVITY; FENNEL; FOOD ANALYSIS; GENOTOXICITY; GLUCURONIDATION; HUMAN; LIVER CELL CARCINOMA; LIVER TOXICITY; NONHUMAN; PHYTOCHEMISTRY; PLANT SEED; PRIORITY JOURNAL; REVIEW; TEA;

EID: 84864921126     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/860542     Document Type: Review

References (63)

1. Oktay M., Gulcin I., Kufrevioglu O. I., Determination of in vitro antioxidant activity of fennel (Foeniculum vulgare) seed extracts LWT-Food Science and Technology 2003 36 2 263 271 (Pubitemid 36326035)
2. Mimica-Duki N., Kujundi S., Sokovi M., Couladis M., Essential oil composition and antifungal activity of Foeniculum vulgare Mill. Obtained by different distillation conditions Phytotherapy Research 2003 17 4 368 371 (Pubitemid 36565343)
3. Perry R., Hunt K., Ernst E., Nutritional supplements and other complementary medicines for infantile colic: a systematic review Pediatrics 2011 127 4 720 733
4. Bruyas-Bertholon V., Lachaux A., Dubois J. P., Fourneret P., Letrilliart L., Which treatments for infantile colics? La Presse Médicale 2012 41 7-8 e404 e410
5. Bristol D. W., NTP 3-month toxicity studies of estragole (CAS No. 140-67-0) administered by gavage to F344/N rats and B6C3F1 mice Toxicity Report Series 2011 82 1 111
6. EFSA 2005, Opinion of the scientific committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic. EFSA 282, 1-31, 2005
7. Miraldi E., Comparison of the essential oils from ten samples of fruits of different origin Flavour and Fragrance Journal 1999 14 379 382 (Pubitemid 30071997)
8. Rietjens I. M. C. M., Punt A., Schilter B., Scholz G., Delatour T., van Bladeren P. J., In silico methods for physiologically based biokinetic models describing bioactivation and detoxification of coumarin and estragole: implications for risk assessment Molecular Nutrition and Food Research 2010 54 2 195 207
9. Brand N., Hager H., Hnsel R., Keller K., Rimpler H., Schneider G., Foeniculum Hagers Handbuch der Pharmazeutischen Praxis 1993 5 Berlin, Germany Springer 156 181
10. Toth L., Untersuchungen uber das atherische Ol von Foeniculum vulgare Planta Medica 1967 15 371 389
11. Trenkle K., Recent studies on fennel (Foeniculum vulgare M.) 2. The volatile oil of the fruit, herbs and roots of fruit-bearing plants Pharmazie 1972 27 5 319 324
12. Kunzemann J., Herrmann K., Isolation and identification of flavon(ol)-O-glycosides in caraway (Carum carvi L.), fennel (Foeniculum vulgare Mill.), anise (Pimpinella anisum L.), and coriander (Coriandrum sativum L.), and of flavon-C-glycosides in aniseI. Phenolics of spices Zeitschrift fr Lebensmittel-Untersuchung und -Forschung 1977 164 3 194 200
13. Murray R. D. H., Mendez J., Brown S. A., The Natural Coumarins. Occurrence, Chemistry, Biochemistry 1982 Chichester, UK Wiley-Interscience, John Wiley Sons
14. Bilia A. R., Fumarola M., Gallori S., Mazzi G., Vincieri F. F., Identification by HPLC-DAD and HPLC-MS analyses and quantification of constituents of fennel teas and decoctions Journal of Agricultural and Food Chemistry 2000 48 10 4734 4738
15. Tschiggerl C., Bucar F., Volatile fraction of lavender and bitter fennel infusion extracts Natural Product Communications 2010 5 9 1431 1436
16. Czygan F. C., Fenchel S., Wichtl M., Teedrogen 1989 2nd Stuttgart, Germany Wissenschaftliche Verlagsgesellschaft 171 173
17. Barazani O., Cohen Y., Fait A., Diminshtein S., Dudai N., Ravid U., Putievsky E., Friedman J., Chemotypic differentiation in indigenous populations of Foeniculum vulgare var. vulgare in Israel Biochemical Systematics and Ecology 2002 30 8 721 731
18. Miguel M. G., Cruz C., Faleiro L., Simes M. T. F., Figueiredo A. C., Barroso J. G., Pedro L. G., Foeniculum vulgare essential oils: chemical composition, antioxidant and antimicrobial activities Natural Product Communications 2010 5 2 319 328
19. Piccaglia R., Marotti M., Characterization of some Italian types of wild fennel (Foeniculum vulgare mill.) Journal of Agricultural and Food Chemistry 2001 49 1 239 244 (Pubitemid 32104516)
20. Daz M. C., Pérez-Coello M. S., Esteban J., Sanz J., Comparison of the volatile composition of wild fennel samples (Foeniculum vulgare Mill.) from Central Spain Journal of Agricultural and Food Chemistry 2006 54 18 6814 6818 (Pubitemid 44426963)
21. Telci I., Demirtas I., Sahin A., Variation in plant properties and essential oil composition of sweet fennel (Foeniculum vulgare Mill.) fruits during stages of maturity Industrial Crops and Products 2009 30 1 126 130
22. Farmacopeia Portuguesa, Monografias do Funcho amargo e Doce, Fruto 1995 8th Lisboa, Portugal Instituto Nacional de Farmacia e do Medicamento (INFARMED)
23. Shahat A. A., Ibrahim A. Y., Hendawy S. F., Omer E. A., Hammouda F. M., Abdel-Rahman F. H., Saleh M. A., Chemical composition, antimicrobial and antioxidant activities of essential oils from organically cultivated fennel cultivars Molecules 2011 16 2 1366 1377
24. Zangouras A., Caldwell J., Hutt A. J., Smith R. L., Dose dependent conversion of estragole in the rat and mouse to the carcinogenic metabolite, 1′-hydroxyestragole Biochemical Pharmacology 1981 30 11 1383 1386 (Pubitemid 11035411)
25. Sangster S. A., Caldwell J., Hutt A. J., The metabolic disposition of [methoxy- 14 C]-labelled trans-anethole, estragole and p -propylanisole in human volunteers Xenobiotica 1987 17 10 1223 1232 (Pubitemid 17145851)
26. Rietjens I. M. C. M., Huseiny W. A., Boersma M. G., Flavonoids and alkenylbenzenes: new concepts in bioactivation studies Chemico-Biological Interactions 2011 192 1-2 87 95
27. Anthony A., Caldwell J., Gutt A. J., Smith R. L., Metabolism of estragole in rat and mouse and influence of dose size on excretion of the proximate carcinogen 1′-hydroxyestragole Food and Chemical Toxicology 1987 25 11 799 806 (Pubitemid 18017569)
28. Alhusainy W., Paini A., Punt A., Louisse J., Spenkelink A., Vervoort J., Delatour T., Scholz G., Schilter B., Adams T., van Bladeren P. J., Rietjens I. M. C. M., Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect Toxicology and Applied Pharmacology 2010 245 2 179 190
29. Boberg E. W., Miller E. C., Miller J. A., Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1′-sulfooxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1′-hydroxysafrole in mouse liver Cancer Research 1983 43 11 5163 5173 (Pubitemid 14227494)
30. Miller E. C., Swanson A. B., Phillips D. H., Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole Cancer Research 1983 43 3 1124 1134 (Pubitemid 13160033)
31. Paini A., Punt A., Viton F., Scholz G., Delatour T., Marin-Kuan M., Schilter B., van Bladeren P. J., Rietjens I. M. C. M., A physiologically based biodynamic (PBBD) model for estragole DNA binding in rat liver based on in vitro kinetic data and estragole DNA adduct formation in primary hepatocytes Toxicology and Applied Pharmacology 2010 245 1 57 66
32. Randerath K., Haglund R. E., Phillips D. H., Reddy M. V., 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice Carcinogenesis 1984 5 12 1613 1622 (Pubitemid 15127027)
33. Punt A., Delatour T., Scholz G., Schilter B., Van Bladeren P. J., Rietjens I. M. C. M., Tandem mass spectrometry analysis of N2-(trans- isoestragol- 3′-yl)-2′-deoxyguanosine as a strategy to study species differences in sulfotransferase conversion of the proximate carcinogen 1′- hydroxyestragole Chemical Research in Toxicology 2007 20 7 991 998 (Pubitemid 47204812)
34. Smith R. L., Adams T. B., Doull J., Feron V. J., Goodman J. I., Marnett L. J., Portoghese P. S., Waddell W. J., Wagner B. M., Rogers A. E., Caldwell J., Sipes I. G., Safety assessment of allylalkoxybenzene derivatives used as flavouring substancesmethyl eugenol and estragole Food and Chemical Toxicology 2002 40 7 851 870 (Pubitemid 34626695)
35. ESCF European Commission, Opinion of the Scientific Commitee on Food on Estragole (1-allyl-4-methoxybenzene). 2001
36. Guenthner T. M., Luo G., Investigation of the role of the 2′,3′-epoxidation pathway in the bioactivation and genotoxicity of dietary allylbenzene analogs Toxicology 2001 160 13 47 58 (Pubitemid 32200463)
37. Stillwell W. G., Carman M. J., Bell L., Horning M. G., The metabolism of safrole and 2′,3′ epoxysafrole in the rat and guinea pig Drug Metabolism and Disposition 1974 2 6 489 498
38. Solheim E., Scheline R. R., Metabolism of alkenebenzene derivatives in the rat. I. p Methoxyallylbenzene (estragole) and p methoxypropenylbenzene (anethole) Xenobiotica 1973 3 8 493 510
39. Iyer L. V., Ho M. N., Shinn W. M., Bradford W. W., Tanga M. J., Nath S. S., Green C. E., Glucuronidation of 1′-hydroxyestragole (1′-HE) by human UDP-glucuronosyltransferases UGT2B7 and UGT1A9 Toxicological Sciences 2003 73 1 36 43 (Pubitemid 36609083)
40. Czernik P. J., Little J. M., Barone G. W., Raufman J. P., Radominska-Pya A., Glucuronidation of estrogens and retinoic acid and expression of UDP-glucuronosyltransferase 2B7 in human intestinal mucosa Drug Metabolism and Disposition 2000 28 10 1210 1216
41. Strassburg C. P., Nguyen N., Manns M. P., Tukey R. H., Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium Molecular Pharmacology 1998 54 4 647 654 (Pubitemid 28480967)
42. Drinkwater N. R., Miller E. C., Miller J. A., Pitot H. C., Hepatocarcinogenicity of estragole (1 Allyl 4 methoxybenzene) and 1 Hydroxyestragole in the mouse and mutagenicity of 1′ acetoxyestragole in bacteria Journal of the National Cancer Institute 1976 57 6 1323 1331 (Pubitemid 8009095)
43. Caldwell J., Sutton J. D., Influence of dose size on the disposition of trans-[methoxy- 14 C]anethole in human volunteers Food and Chemical Toxicology 1988 26 2 87 91
44. Hoffmann D., Fennel fruit, estragole and the breast feeding mother. http://www.herbcraft.org/hoffmannfennel.html
45. zbek H., Ura S., Dlger H., Bayram I., Tuncer I., ztrk G., ztrk A., Hepatoprotective effect of Foeniculum vulgare essential oil Fitoterapia 2003 74 3 317 319 (Pubitemid 36506795)
46. Tripathi P., Tripathi R., Patel R. K., Pancholi S. S., Investigation of antimutagenic potential of Foeniculum vulgare essential oil on cyclophosphamide induced genotoxicity and oxidative stress in mice. Drug and Chemical Toxicology. In press
47. Mohamad R. H., El-Bastawesy A. M., Abdel-Monem M. G., Noor A. M., Al-Mehdar H. A., Sharawy S. M., El-Merzabani M. M., Antioxidant and anticarcinogenic effects of methanolic extract and volatile oil of fennel seeds (Foeniculum vulgare) Journal of Medicinal Food 2011 14 986 1001
48. Martins C., Cao R., Cole K. J., Phillips D. H., Laires A., Rueff J., Rodrigues A. S., Estragole: a weak direct-acting food-borne genotoxin and potential carcinogen Mutation Research 2012 747 1 86 92
49. Muzolf-Panek M., Gliszczyska-wigo A., De Haan L., Aarts J. M. M. J. G., Szymusiak H., Vervoort J. M., Tyrakowska B., Rietjens I. M. C. M., Role of catechin quinones in the induction of EpRE-mediated gene expression Chemical Research in Toxicology 2008 21 12 2352 2360
50. Firenzuoli F., Gori L., Mascherini V., Vannacci A., Floridia M., Poster presentation. The safety of fennel tea: epigallocatechin gallate and phenolic compounds discovered in fennel tea inhibit estragole toxicity 194 Proceedings of the European Congress of Integrative Medicine 2011 Berlin, Germany
51. Alhusainy W., van den Berg S., Paini A., Campana A, Asselman M, Spenkelink A, Punt A, Scholz G, Schilter B, Adams T, van Bladeren P, Rietjens I., Matrix modulation of the bioactivation of estragole by constituents of different alkenylbenzene-containing herbs and spices and physiologically-based biokinetic (PBBK) modeling of possible in vivo effects. Toxicological Sciences. In press
52. Simmons J. E., Application of physiologically based pharmacokinetic modelling to combination toxicology Food and Chemical Toxicology 1996 34 11-12 1067 1073 (Pubitemid 27124181)
53. Lee-Hilz Y. Y., Boerboom A. M. J. F., Westphal A. H., Van Berkel W. J. H., Aarts J. M. M. J. G., Rietjens I. M. C. M., Pro-oxidant activity of flavonoids induces EpRE-mediated gene expression Chemical Research in Toxicology 2006 19 11 1499 1505 (Pubitemid 44863492)
54. Raffo A., Nicoli S., Leclercq C., Quantification of estragole in fennel herbal teas: implications on the assessment of dietary exposure to estragole Food and Chemical Toxicology 2011 49 2 370 375
55. AIRTUM (Italian Association of Cancer Registers) official database, March 2012
56. Dybing E., O'Brien J., Renwick A. G., Sanner T., Risk assessment of dietary exposures to compounds that are genotoxic and carcinogenic-an overview Toxicology Letters 2008 180 2 110 117
57. Key T. J., Allen N. E., Spencer E. A., Travis R. C., The effect of diet on risk of cancer The Lancet 2002 360 9336 861 868 (Pubitemid 35257961)
58. Barlow S., Renwick A. G., Kleiner J., Bridges J. W., Busk L., Dybing E., Edler L., Eisenbrand G., Fink-Gremmels J., Knaap A., Kroes R., Liem D., Mller D. J. G., Page S., Rolland V., Schlatter J., Tritscher A., Tueting W., Wrtzen G., Risk assessment of substances that are both genotoxic and carcinogenic. Report of an International Conference organized by EFSA and WHO with support of ILSI Europe Food and Chemical Toxicology 2006 44 10 1636 1650
59. Peto R., Pike M. C., Bernstein L., The TD50: a proposed general convention for the numerical description of the carcinogenic potency of chemicals in chronic-exposure animal experiments Environmental Health Perspectives 1984 58 1 8 (Pubitemid 15134227)
60. Galli C. L., Marinovich M., Lotti M., Is the acceptable daily intake as presently used an axiom or a dogma? Toxicology Letters 2008 180 2 93 99
61. Lehman-McKeeman L. D., Rodriguez P. A., Takigiku R., Caudill D., Fey M. L., d-Limonen-induced male rat-specific nephrotoxicity: evaluation of the association between d-limonene and (2u)-globulin Toxicology and Applied Pharmacology 1989 99 2 250 259 (Pubitemid 19201313)
62. Restani P., Campagner P., Fiecchi A., Resmini P., Galli C. L., Identification of spinacine as the principal reaction product of -casein with formaldehyde in cheese Food and Chemical Toxicology 1988 26 5 441 446
63. Gaylor D. W., Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens? Regulatory Toxicology and Pharmacology 2005 41 2 128 133 (Pubitemid 40187182)